Irritable Bowel Syndrome (IBS) Clinical Trials

15 recruiting

Irritable Bowel Syndrome (IBS) Trials at a Glance

13 actively recruiting trials for irritable bowel syndrome (ibs) are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Athens, Barcelona, and Bobigny. Lead sponsors running irritable bowel syndrome (ibs) studies include Attikon Hospital, Chen QiYi, and Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA).

Browse irritable bowel syndrome (ibs) trials by phase

Treatments under study

About Irritable Bowel Syndrome (IBS) Clinical Trials

Looking for clinical trials for Irritable Bowel Syndrome (IBS)? There are currently 15 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Irritable Bowel Syndrome (IBS) trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Irritable Bowel Syndrome (IBS) clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 113 of 13 trials

Recruiting
Not Applicable

Evaluating the Added Benefit of Osteopathic Care to a Flexi-FODMAP Diet in Fibromyalgia Patients With Irritable Bowel Syndrome

Fibromyalgia (FM)Irritable Bowel Syndrome (IBS)
Universitair Ziekenhuis Brussel96 enrolled1 locationNCT07176078
Recruiting
Not Applicable

Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS)Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl330 enrolled12 locationsNCT06681012
Recruiting
Phase 1Phase 2

Safety and Efficacy of Lyophilized Faecal Microbiota Transplantation Via Capsules in Treatment of Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS)
University of Rijeka70 enrolled1 locationNCT07481422
Recruiting
Not Applicable

Irritable Bowel Syndrome and Control Volunteers: Diet Challenge

Irritable Bowel Syndrome (IBS)
University of California, Los Angeles72 enrolled1 locationNCT06668922
Recruiting

Diet and Motility in IBS

Irritable Bowel Syndrome (IBS)
Children's Hospital of Philadelphia90 enrolled1 locationNCT07283341
Recruiting

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

Ulcerative Colitis (UC)Crohn Disease (CD)Autism Spectrum Disorder+6 more
Chen QiYi4,000 enrolled1 locationNCT07261826
Recruiting
Not Applicable

A Randomized Crossover Trial of Bright Light Therapy in Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS)
Medical University of South Carolina30 enrolled1 locationNCT06676488
Recruiting
Not Applicable

Mechanism of FODMAP Restriction on FGID Patients

Functional DyspepsiaIrritable Bowel Syndrome (IBS)Functional Gastrointestinal Disorders (FGIDs)
Universiti Kebangsaan Malaysia Medical Centre60 enrolled1 locationNCT07000227
Recruiting
Not Applicable

Exclude or Expose in Irritable Bowel Syndrome: What Works for Whom and How?

Gastrointestinal DiseaseIntestinal DiseasesIrritable Bowel Syndrome (IBS)
University of Melbourne200 enrolled1 locationNCT06940596
Recruiting
Not Applicable

Evaluate the Effect of Synbiotics in Irritable Bowel Syndrome

Irritable Bowel Syndrome (IBS)
Universiti Sains Malaysia20 enrolled1 locationNCT06647043
Recruiting

GWAS to Identify Predictive Genetic Factors for the Success of Dietary Intervention in the Treatment of IBS Symptoms

Mediterranean DietIrritable Bowel Syndrome (IBS)Genome-wide Association Study+2 more
Attikon Hospital100 enrolled1 locationNCT06912828
Recruiting

Prospective Observational Study of Naturopathic Approaches to IBS

Irritable Bowel Syndrome (IBS)
National University of Natural Medicine50 enrolled1 locationNCT06721624
Recruiting
Not Applicable

VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders

Functional DyspepsiaIrritable Bowel Syndrome (IBS)Functional Abdominal Pain Disorders+1 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)208 enrolled1 locationNCT06665867